Cloopen Group Holding Limited (OTC: RAASY) (“Cloopen” or the “Company”) today announced that the New York Stock Exchange (“NYSE”) has scheduled a hearing for October 12, 2023 to review the Company’s appeal against the NYSE Regulation staff’s determination to delist the Company’s American depositary shares.
The Company will keep the market informed of any significant developments related to this matter.
PRNewswire
previous
FEops Receives FDA Clearance for Its AI-Based Anatomical Analysis Capabilities
next
